CLX vs PATH · P/E 15, rev $7.10B vs P/E 19, rev $1.61B
The Clorox Company (CLX) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. Revenue was up 0.2% from 2024-06-30 to 2025-06-30. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the CLX and PATH stock pages for the full models.
Not investment advice.